Moreover, the alternative activation of survival pathways in XPO1-mutated CLL cells suggests the XPO1 mutation may be skewing the molecular dependence of specific survival pathways for continued proliferation of neoplastic B cells and encourages the emergence of additional factors to contribute to leukemogenesis. This evidence concerns the gene XPO1 and B-cell chronic lymphocytic leukemia.